Titan Pharmaceuticals, Inc.(NASDAQ : TTNP)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-1.88%||162.11||0.7%||$1086.81m|
|MRK||Merck & Co., Inc.||-0.79%||76.62||0.7%||$1018.44m|
|LLY||Eli Lilly & Co.||-1.68%||218.47||1.1%||$906.20m|
|BMY||Bristol-Myers Squibb Co.||-0.34%||66.54||1.0%||$643.98m|
|ANVS||Annovis Bio, Inc.||2.78%||92.55||0.0%||$317.09m|
|CNST||Constellation Pharmaceuticals, Inc.||-0.18%||33.76||0.0%||$107.09m|
Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.